Holen Sie sich die Stockscreener-App
19.73
2.60%
-0.4669
Schlusskurs vom Vortag:
$20.20
Offen:
$20.09
24-Stunden-Volumen:
35,675
Relative Volume:
0.13
Marktkapitalisierung:
$543.98M
Einnahmen:
$320.35M
Nettoeinkommen (Verlust:
$-75.01M
KGV:
-8.2383
EPS:
-2.3953
Netto-Cashflow:
$-113.17M
1W Leistung:
-1.82%
1M Leistung:
+2.80%
6M Leistung:
+32.22%
1J Leistung:
-11.85%
1-Tages-Spanne:
$19.62
$20.09
1-Wochen-Bereich:
$19.38
$20.34
52-Wochen-Spanne:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
19.77 | 555.81M | 320.35M | -75.01M | -113.17M | -2.3953 |
TMO
Thermo Fisher Scientific Inc
|
603.14 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.91 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.61 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.62 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.37 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Hochstufung | UBS | Neutral → Buy |
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Public Employees Retirement System of Ohio Makes New Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
Hsieh Ming Surrenders 4,392 Shares of Fulgent Genetics at $19.59 Each - kalkinemedia.com
Fulgent Genetics CFO Kim Paul Surrenders 2,087 Shares at $19.59 Each - Kalkine Media
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock By Investing.com - Investing.com South Africa
FLGT Q2 2026 Earnings: Wider-Than-Expected Loss of -$0.58 Pressures SharesEarnings Revision Downgrade - vinanet.vn
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock - Investing.com India
Fulgent Genetics (NASDAQ:FLGT) COO Sells 2,127 Shares - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $32,891.18 in Stock - MarketBeat
Fulgent Genetics (FLGT) officer plans stock sale to cover taxes - Stock Titan
BlackRock Inc. Makes New $46.92 Million Investment in Fulgent Genetics, Inc. $FLGT - marketbeat.com
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded at Wall Street Zen - MarketBeat
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Nigeria
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock - Investing.com India
Jian Xie Sells 1,193 Shares of Fulgent Genetics (NASDAQ:FLGT) Stock - MarketBeat
Fulgent Genetics COO Xie Jian disposes of $23,747 in company stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) holder plans tax-driven share sale - Stock Titan
Fulgent Genetics (NASDAQ:FLGT) Insider Hanlin Gao Sells 939 Shares - MarketBeat
Fulgent (FLGT) Technicals: Slides 0.10% to $19.90 at the Close; the Near-Term Reference Band Stretches From $18.90 to $20.89 under the Current SnapshotPrice Action Signals - vinanet.vn
Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Share Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations - tradersunion.com
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingView
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Complicated Financial Landscape in Healthcare - DirectorsTalk Interviews
FLGT Q1 2026 Earnings: Wider-than-Expected Loss Despite Positive Stock MovementEarnings Miss Alert - vinanet.vn
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets - Yahoo Finance
Fulgent Deadline Alert - TMX Newsfile
FLGT Maintained by Piper Sandler -- Price Target Raised to $19.0 - GuruFocus
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Fulgent Genetics Inc (7F0) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6%, Shares Tumble 18%Pre-Announcement Alert - vinanet.vn
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6% as Shares Slide 18%Revenue Miss Report - vinanet.vn
Fulgent Genetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ... By GuruFocus - Investing.com Canada
Earnings call transcript: Fulgent Genetics cuts 2026 outlook after q2 miss - Investing.com Nigeria
FLGT Looks 16.7% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Genetics, Inc. Revises Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Fulgent Genetics cuts FY26 revenue guidance amid billing delays - scanx.trade
Behavioral Patterns of FLGT and Institutional Flows - Stock Traders Daily
Fulgent Genetics CFO Kim Paul Executes Tax-Driven Share Withholding, Sells 2,747 Shares at $19.67 Each - Kalkine Media
Fulgent Genetics Inc (FLGT) Cash Flow - TradingKey
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):